Literature DB >> 9934675

Molecular analysis of ovine prion protein identifies similarities between BSE and an experimental isolate of natural scrapie, CH1641.

J Hope, S C Wood, C R Birkett, A Chong, M E Bruce, D Cairns, W Goldmann, N Hunter, C J Bostock.   

Abstract

New variant Creutzfeldt-Jakob disease (vCJD) and bovine spongiform encephalopathy (BSE) are caused by the same strain of pathogen and, as sheep can develop experimental BSE, this has raised concern that humans may be at risk from eating mutton if BSE has naturally transmitted to sheep. Biochemical typing of abnormal prion proteins (PrPsc) has been suggested to detect BSE in sheep. Although this approach is ingenuous, we can now report biochemical evidence of strain variation in contemporary and archival brain tissue from cases of experimental BSE or experimental and natural scrapie in sheep. Interestingly, we found at least one isolate of natural scrapie (CH 1641) with a very similar, but not identical, PrPsc profile to BSE but which differs from BSE in its transmission characteristics to mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9934675     DOI: 10.1099/0022-1317-80-1-1

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  50 in total

Review 1.  The molecular pathology of CJD: old and new variants.

Authors:  G S Jackson; J Collinge
Journal:  Mol Pathol       Date:  2001-12

2.  Molecular analysis of cases of Italian sheep scrapie and comparison with cases of bovine spongiform encephalopathy (BSE) and experimental BSE in sheep.

Authors:  Romolo Nonno; Elena Esposito; Gabriele Vaccari; Michela Conte; Stefano Marcon; Michele Di Bari; Ciriaco Ligios; Giovanni Di Guardo; Umberto Agrimi
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

3.  Differentiating ovine BSE from CH1641 scrapie by serial protein misfolding cyclic amplification.

Authors:  Maged M Taema; Ben C Maddison; Leigh Thorne; Keith Bishop; Jonathan Owen; Nora Hunter; Claire A Baker; Linda A Terry; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2012-07       Impact factor: 2.695

4.  Use of thermolysin in the diagnosis of prion diseases.

Authors:  Jonathan P Owen; Ben C Maddison; Garry C Whitelam; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2007-02       Impact factor: 2.695

Review 5.  Molecular neurology of prion disease.

Authors:  J Collinge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

6.  Molecular profiling of ovine prion diseases by using thermolysin-resistant PrPSc and endogenous C2 PrP fragments.

Authors:  Jonathan P Owen; Helen C Rees; Ben C Maddison; Linda A Terry; Leigh Thorne; Roy Jackman; Garry C Whitelam; Kevin C Gough
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

7.  Biological and biochemical characterization of sheep scrapie in Japan.

Authors:  Motohiro Horiuchi; Takuya Nemoto; Naotaka Ishiguro; Hidefumi Furuoka; Shirou Mohri; Morikazu Shinagawa
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  Stability of murine scrapie strain 87V after passage in sheep and comparison with the CH1641 ovine strain.

Authors:  Lorenzo González; Francesca Chianini; Nora Hunter; Scott Hamilton; Louise Gibbard; Stuart Martin; Mark P Dagleish; Sílvia Sisó; Samantha L Eaton; Angela Chong; Lynne Algar; Martin Jeffrey
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

9.  Prions of ruminants show distinct splenotropisms in an ovine transgenic mouse model.

Authors:  Thierry Baron; Anna Bencsik; Eric Morignat
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

10.  Transgenic mice expressing porcine prion protein resistant to classical scrapie but susceptible to sheep bovine spongiform encephalopathy and atypical scrapie.

Authors:  Juan Carlos Espinosa; María Eugenia Herva; Olivier Andréoletti; Danielle Padilla; Caroline Lacroux; Hervé Cassard; Isabelle Lantier; Joaquin Castilla; Juan Maria Torres
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.